LifeStance Health Group, Inc. Goodwill, Acquired During Period
LifeStance Health Group, Inc. (LFST) reported Goodwill, Acquired During Period of $11.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-08-06
- LifeStance Health Group, Inc. goodwill, acquired during period for the quarter ending 2026-06-30 was $7.56M.
- LifeStance Health Group, Inc. goodwill, acquired during period for the quarter ending 2026-03-31 was $3.65M.
- LifeStance Health Group, Inc. goodwill, acquired during period for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- LifeStance Health Group, Inc. goodwill, acquired during period for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- LifeStance Health Group, Inc. goodwill, acquired during period for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- LifeStance Health Group, Inc. goodwill, acquired during period for fiscal 2023 was $20.73M, a 69.65% decline from fiscal 2022.
- LifeStance Health Group, Inc. goodwill, acquired during period for fiscal 2022 was $68.31M, a 36.75% decline from fiscal 2021.
- LifeStance Health Group, Inc. goodwill, acquired during period for fiscal 2021 was $108.00M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.21M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $20.73M 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $20.73M 10-Q · filed 2023-11-08 | $43.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $20.73M 10-Q · filed 2023-08-09 | $43.43M derived: sum of 3 quarters · filed 2024-02-28 | $49.82M derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-03-31 | $20.73M 10-Q · filed 2023-05-10 | $43.43M derived: sum of 2 quarters · filed 2024-02-28 | $49.82M derived: sum of 3 quarters · filed 2024-02-28 | $64.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-12-31 | $22.69M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $29.09M derived: sum of 2 quarters · filed 2024-02-28 | $43.61M derived: sum of 3 quarters · filed 2024-02-28 | $68.31M 10-K · filed 2024-02-28 |
| 2022-09-30 | $6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $20.92M derived: sum of 2 quarters · filed 2022-11-09 | $45.62M 10-Q · filed 2022-11-09 | $90.14M derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-06-30 | $14.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $39.23M 10-Q · filed 2022-08-10 | $83.74M derived: sum of 3 quarters · filed 2023-03-09 | $105.94M derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-03-31 | $24.70M 10-Q · filed 2022-05-11 | $69.22M derived: sum of 2 quarters · filed 2023-03-09 | $91.41M derived: sum of 3 quarters · filed 2023-03-09 | |
| 2021-12-31 | $44.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $66.71M derived: sum of 2 quarters · filed 2023-03-09 | $108.00M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $22.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $63.48M 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $41.29M 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $169.02M 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |